Cargando…
The increased ratio of 11β-hydroxysteroid dehydrogenase type 1 versus 11β-hydroxysteroid dehydrogenase type 2 in chronic periodontitis irrespective of obesity
11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1), which converts inactive cortisone to active cortisol, has been reported to play an important role in metabolic diseases as well as chronic inflammatory diseases. The involvement of 11β-HSD1 in chronic periodontitis was investigated in the present s...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4715141/ https://www.ncbi.nlm.nih.gov/pubmed/26835222 http://dx.doi.org/10.1186/s40064-016-1679-6 |
_version_ | 1782410424886493184 |
---|---|
author | Nakata, Takaya Fujita, Atsuko Umeda, Makoto Yoshida, Hiroaki Inami, Kaoru Masuzaki, Hiroaki Sawai, Hirofumi |
author_facet | Nakata, Takaya Fujita, Atsuko Umeda, Makoto Yoshida, Hiroaki Inami, Kaoru Masuzaki, Hiroaki Sawai, Hirofumi |
author_sort | Nakata, Takaya |
collection | PubMed |
description | 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1), which converts inactive cortisone to active cortisol, has been reported to play an important role in metabolic diseases as well as chronic inflammatory diseases. The involvement of 11β-HSD1 in chronic periodontitis was investigated in the present study. The relationship between the levels of 11β-HSD1, chronic periodontitis, and body mass index (BMI) was analyzed. The expression of 11β-HSD1 mRNA was significantly higher in the chronic periodontitis group than in the control group. Since the expression of 11β-HSD2, which converts active cortisol to inactive cortisone, was slightly lower in the chronic periodontitis group than in the controls, the ratio of 11β-HSD1 versus 11β-HSD2 was significantly higher in the chronic periodontitis group than in the controls. A correlation was not observed between BMI and the level of 11β-HSD1 or between BMI and the ratio of 11β-HSD1 versus 11β-HSD2. These results suggested that an increase in the ratio of 11β-HSD1 versus 11β-HSD2 was associated with chronic periodontitis irrespective of obesity. |
format | Online Article Text |
id | pubmed-4715141 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-47151412016-01-31 The increased ratio of 11β-hydroxysteroid dehydrogenase type 1 versus 11β-hydroxysteroid dehydrogenase type 2 in chronic periodontitis irrespective of obesity Nakata, Takaya Fujita, Atsuko Umeda, Makoto Yoshida, Hiroaki Inami, Kaoru Masuzaki, Hiroaki Sawai, Hirofumi Springerplus Research 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1), which converts inactive cortisone to active cortisol, has been reported to play an important role in metabolic diseases as well as chronic inflammatory diseases. The involvement of 11β-HSD1 in chronic periodontitis was investigated in the present study. The relationship between the levels of 11β-HSD1, chronic periodontitis, and body mass index (BMI) was analyzed. The expression of 11β-HSD1 mRNA was significantly higher in the chronic periodontitis group than in the control group. Since the expression of 11β-HSD2, which converts active cortisol to inactive cortisone, was slightly lower in the chronic periodontitis group than in the controls, the ratio of 11β-HSD1 versus 11β-HSD2 was significantly higher in the chronic periodontitis group than in the controls. A correlation was not observed between BMI and the level of 11β-HSD1 or between BMI and the ratio of 11β-HSD1 versus 11β-HSD2. These results suggested that an increase in the ratio of 11β-HSD1 versus 11β-HSD2 was associated with chronic periodontitis irrespective of obesity. Springer International Publishing 2016-01-16 /pmc/articles/PMC4715141/ /pubmed/26835222 http://dx.doi.org/10.1186/s40064-016-1679-6 Text en © Nakata et al. 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Research Nakata, Takaya Fujita, Atsuko Umeda, Makoto Yoshida, Hiroaki Inami, Kaoru Masuzaki, Hiroaki Sawai, Hirofumi The increased ratio of 11β-hydroxysteroid dehydrogenase type 1 versus 11β-hydroxysteroid dehydrogenase type 2 in chronic periodontitis irrespective of obesity |
title | The increased ratio of 11β-hydroxysteroid dehydrogenase type 1 versus 11β-hydroxysteroid dehydrogenase type 2 in chronic periodontitis irrespective of obesity |
title_full | The increased ratio of 11β-hydroxysteroid dehydrogenase type 1 versus 11β-hydroxysteroid dehydrogenase type 2 in chronic periodontitis irrespective of obesity |
title_fullStr | The increased ratio of 11β-hydroxysteroid dehydrogenase type 1 versus 11β-hydroxysteroid dehydrogenase type 2 in chronic periodontitis irrespective of obesity |
title_full_unstemmed | The increased ratio of 11β-hydroxysteroid dehydrogenase type 1 versus 11β-hydroxysteroid dehydrogenase type 2 in chronic periodontitis irrespective of obesity |
title_short | The increased ratio of 11β-hydroxysteroid dehydrogenase type 1 versus 11β-hydroxysteroid dehydrogenase type 2 in chronic periodontitis irrespective of obesity |
title_sort | increased ratio of 11β-hydroxysteroid dehydrogenase type 1 versus 11β-hydroxysteroid dehydrogenase type 2 in chronic periodontitis irrespective of obesity |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4715141/ https://www.ncbi.nlm.nih.gov/pubmed/26835222 http://dx.doi.org/10.1186/s40064-016-1679-6 |
work_keys_str_mv | AT nakatatakaya theincreasedratioof11bhydroxysteroiddehydrogenasetype1versus11bhydroxysteroiddehydrogenasetype2inchronicperiodontitisirrespectiveofobesity AT fujitaatsuko theincreasedratioof11bhydroxysteroiddehydrogenasetype1versus11bhydroxysteroiddehydrogenasetype2inchronicperiodontitisirrespectiveofobesity AT umedamakoto theincreasedratioof11bhydroxysteroiddehydrogenasetype1versus11bhydroxysteroiddehydrogenasetype2inchronicperiodontitisirrespectiveofobesity AT yoshidahiroaki theincreasedratioof11bhydroxysteroiddehydrogenasetype1versus11bhydroxysteroiddehydrogenasetype2inchronicperiodontitisirrespectiveofobesity AT inamikaoru theincreasedratioof11bhydroxysteroiddehydrogenasetype1versus11bhydroxysteroiddehydrogenasetype2inchronicperiodontitisirrespectiveofobesity AT masuzakihiroaki theincreasedratioof11bhydroxysteroiddehydrogenasetype1versus11bhydroxysteroiddehydrogenasetype2inchronicperiodontitisirrespectiveofobesity AT sawaihirofumi theincreasedratioof11bhydroxysteroiddehydrogenasetype1versus11bhydroxysteroiddehydrogenasetype2inchronicperiodontitisirrespectiveofobesity AT nakatatakaya increasedratioof11bhydroxysteroiddehydrogenasetype1versus11bhydroxysteroiddehydrogenasetype2inchronicperiodontitisirrespectiveofobesity AT fujitaatsuko increasedratioof11bhydroxysteroiddehydrogenasetype1versus11bhydroxysteroiddehydrogenasetype2inchronicperiodontitisirrespectiveofobesity AT umedamakoto increasedratioof11bhydroxysteroiddehydrogenasetype1versus11bhydroxysteroiddehydrogenasetype2inchronicperiodontitisirrespectiveofobesity AT yoshidahiroaki increasedratioof11bhydroxysteroiddehydrogenasetype1versus11bhydroxysteroiddehydrogenasetype2inchronicperiodontitisirrespectiveofobesity AT inamikaoru increasedratioof11bhydroxysteroiddehydrogenasetype1versus11bhydroxysteroiddehydrogenasetype2inchronicperiodontitisirrespectiveofobesity AT masuzakihiroaki increasedratioof11bhydroxysteroiddehydrogenasetype1versus11bhydroxysteroiddehydrogenasetype2inchronicperiodontitisirrespectiveofobesity AT sawaihirofumi increasedratioof11bhydroxysteroiddehydrogenasetype1versus11bhydroxysteroiddehydrogenasetype2inchronicperiodontitisirrespectiveofobesity |